Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$36.31 - $46.83 $715,779 - $923,159
-19,713 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$35.66 - $44.99 $59,124 - $74,593
-1,658 Reduced 7.76%
19,713 $750,000
Q2 2019

Aug 14, 2019

SELL
$36.57 - $47.97 $28,341 - $37,176
-775 Reduced 3.5%
21,371 $929,000
Q4 2018

Feb 04, 2019

SELL
$41.31 - $52.16 $61,965 - $78,240
-1,500 Reduced 6.34%
22,146 $924,000
Q3 2018

Oct 15, 2018

BUY
$32.85 - $52.0 $25,097 - $39,728
764 Added 3.34%
23,646 $1.17 Million
Q2 2018

Aug 01, 2018

SELL
$27.5 - $39.8 $25,382 - $36,735
-923 Reduced 3.88%
22,882 $733,000
Q1 2018

Apr 16, 2018

BUY
$29.98 - $46.35 $93,477 - $144,519
3,118 Added 15.07%
23,805 $742,000
Q4 2017

Jan 31, 2018

BUY
$31.85 - $46.95 $2,484 - $3,662
78 Added 0.38%
20,687 $944,000
Q3 2017

Nov 08, 2017

BUY
$35.7 - $39.5 $735,741 - $814,055
20,609
20,609 $777,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.